Stryker Corporation (NYSE:SYK) Stock Has Average Price Target of $355.04

Shares of Stryker Corporation (NYSE:SYK) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-eight analysts that are currently covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a hold recommendation and twenty-one have assigned a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $343.73.

A number of equities analysts have recently issued reports on SYK shares. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Stryker in a research report on Wednesday, October 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Stryker in a report on Thursday, October 29th. Leerink Partners cut their target price on shares of Stryker from $403.00 to $353.00 and set an “outperform” rating on the stock in a report on Friday, October 9th. Needham & Company LLC reduced their price target on Stryker from $418.00 to $359.00 and set a “buy” rating for the company in a research report on Friday, October 30th. Finally, Wells Fargo & Company cut their price target on Stryker from $418.00 to $348.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 9th.

Insider Buying and Selling at Stryker

In other news, Director Ronda E. Stryker sold 50,000 shares of Stryker stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $340.10, for a total transaction of $17,005,000.00. Following the completion of the sale, the director directly owned 2,251,375 shares in the company, valued at approximately $765,692,637.50. This trade represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Debra King sold 826 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the completion of the sale, the insider directly owned 6,210 shares of the company’s stock, valued at approximately $2,088,423. This represents a 11.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 351,267 shares of company stock worth $118,197,701 over the last ninety days. 4.60% of the stock is currently owned by company insiders.

Institutional Trading of Stryker

Several institutional investors have recently made changes to their positions in the stock. Community Bank & Trust Waco Texas boosted its holdings in shares of Stryker by 2.3% in the second quarter. Community Bank & Trust Waco Texas now owns 1,395 shares of the medical technology company’s stock valued at $439,000 after acquiring an additional 31 shares in the last quarter. Cornerstone Financial Management LLC increased its holdings in Stryker by 66.0% in the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock valued at $25,000 after purchasing an additional 31 shares during the last quarter. NWF Advisory Services Inc. grew its holdings in shares of Stryker by 2.3% during the second quarter. NWF Advisory Services Inc. now owns 1,472 shares of the medical technology company’s stock worth $463,000 after buying an additional 33 shares in the last quarter. Harold Davidson & Associates Inc. grew its stake in Stryker by 0.4% in the 1st quarter. Harold Davidson & Associates Inc. now owns 8,668 shares of the medical technology company’s stock valued at $2,848,000 after buying an additional 34 shares during the last quarter. Finally, Private Harbour Investment Management & Counsel LLC boosted its stake in shares of Stryker by 0.9% in the 2nd quarter. Private Harbour Investment Management & Counsel LLC now owns 3,927 shares of the medical technology company’s stock valued at $1,236,000 after purchasing an additional 34 shares in the last quarter. 77.09% of the stock is owned by hedge funds and other institutional investors.

Stryker Price Performance

Shares of SYK opened at $325.26 on Wednesday. The company has a quick ratio of 1.30, a current ratio of 2.18 and a debt-to-equity ratio of 0.60. The company has a 50 day moving average of $292.37 and a 200-day moving average of $323.59. Stryker has a twelve month low of $267.00 and a twelve month high of $389.33. The stock has a market capitalization of $123.83 billion, a P/E ratio of 21.49, a P/E/G ratio of 2.11 and a beta of 0.78.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, October 29th. The medical technology company reported $3.52 earnings per share for the quarter, missing analysts’ consensus estimates of $3.55 by ($0.03). Stryker had a return on equity of 23.74% and a net margin of 13.78%. The business had revenue of $6.52 billion during the quarter, compared to analyst estimates of $6.62 billion. During the same quarter in the prior year, the company earned $3.19 EPS. The company’s revenue was up 7.6% on a year-over-year basis. As a group, equities research analysts forecast that Stryker will post 14.84 EPS for the current fiscal year.

Stryker Company Profile

Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings.

The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.

Founded in 1941 by orthopedic surgeon Dr.